FDA approved Duvyzat oral medication for the treatment of Duchenne Muscular Dystrophy in patients six years of age and older
The U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older. Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic…